4//SEC Filing
Altarac David 4
Accession 0001104659-21-128056
CIK 0001724344other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:06 PM ET
Size
6.8 KB
Accession
0001104659-21-128056
Insider Transaction Report
Form 4
Altarac David
Chief Medical Officer
Transactions
- Award
Common Stock
2021-10-19+25,000→ 50,000 total - Sale
Common Stock
2021-10-19$3.19/sh−3,759$11,991→ 46,241 total
Footnotes (2)
- [F1]Acquired as a result of the satisfaction of the performance criteria of the underlying award as of the date stated. Fifty percent of this award vested on such date and the remaining fifty percent will vest on the first anniversary of such date, subject to the reporting person's continued employment with the Company.
- [F2]Represents shares sold solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on October 19, 2021. The number of shares sold was determined based on the closing price on the last trading day prior to vesting, which was October 18, 2021.
Documents
Issuer
Entasis Therapeutics Holdings Inc.
CIK 0001724344
Entity typeother
Related Parties
1- filerCIK 0001792615
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 4:06 PM ET
- Size
- 6.8 KB